4//SEC Filing
Markels Michael 4
Accession 0001181431-12-044160
CIK 0001385830other
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 7:36 PM ET
Size
5.8 KB
Accession
0001181431-12-044160
Insider Transaction Report
Form 4
NeurogesX IncNGSX
Markels Michael
VP, Commercial Ops and Bus Dev
Transactions
- Award
Stock Option (right to buy)
2012-08-05+110,000→ 110,000 totalExercise: $0.22From: 2013-03-13Exp: 2022-03-13→ Common Stock (110,000 underlying)
Footnotes (1)
- [F1]Subject to the termination of the option, if registrant does not execute an Amended and Restated Executive Employment Agreement substantially on the terms reviewed and approved by the Company's Board and/or Compensation Committee of the Board within 30 days of August 5, 2012, the above option shall terminate on September 4, 2012, otherwise, 50% of the shares subject to the option shall vest on March 13, 2013, and an additional 1/12 of the remaining shares subject to the option shall vest on the 13th of each month thereafter until all such shares vest, subject on each of the foregoing dates to the optionee remaining a service provider to the Company on such dates.
Documents
Issuer
NeurogesX Inc
CIK 0001385830
Entity typeother
Related Parties
1- filerCIK 0001394530
Filing Metadata
- Form type
- 4
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 7:36 PM ET
- Size
- 5.8 KB